Reata will be hosting the online Webex meetings in September to discuss recent CARDINAL Phase 2 data plus study updates and next steps for the ongoing Phase 3 portion of CARDINAL. Reata is evaluating the safety and effectiveness of an investigational medication, bardoxolone methyl, in Alport syndrome.
Meeting Dates and Times
There will be two meetings in the next few weeks. The same information will be presented at both meetings, so pick the time that best fits your schedule:
Tuesday, September 12 at 10:00am PDT/1:00pm EDT
Thursday, September 14 at 5:00pm PST/8:00pm EDT
The purpose of these meetings is to provide an update on the Phase 2 study and introduce the Phase 3 portion of the study to the patient community, including study participation, eligibility criteria, how to enroll, study status, etc. The Webex meetings will include time at the end for Reata to answer questions from the participants.
This event is aimed at any interested individuals affected by Alport syndrome and/or family members.
What is a Webex Meeting?
A Webex is an online meeting that includes audio and screen sharing. All you need is an internet connection!
How to Participate
To register for one of the online Webex meetings, please contact Hanh Nguyen at
In order to receive the link to join the Webex meeting, you must register in advance.
Recording of Previous Webex Meeting
Additional information about bardoxolone methyl, the medication being used in the study, was presented to the patient community through an online Webex meeting in December 2016. If you would like to listen to the recording of the December meeting, it is available on the ASF YouTube channel.
The Alport Syndrome Foundation improves the lives of those affected by Alport Syndrome through education, empowerment, advocacy, and research.
Alport Syndrome Foundation • P.O. Box 4130 • Scottsdale, AZ 85261-4130
Phone Number: (480) 800-3510
Follow us on social media!
To update your email or other contact information, request additional information about an item in a mailing, or submit other questions, please contact us at ASFNews@alportsyndrome.org.
Would you like to forward this email to a friend? Click here.